Novo expands research collaboration with US universities

A collaboration between Novo Nordisk and Massachusetts Institute of Technology (MIT) resulted in robotic pill, SOMA. Now, the company is continuing, and expanding, the partnership.
by CHRISTIAN BUNDGAARD, translated by daniel pedersen

Novo Nordisk is continuing to explore alternative drug delivery technologies to conventional syringes and pen injectors.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading